<scp>MiR</scp>‐205‐5p promotes lung cancer progression and is valuable for the diagnosis of lung cancer

Abstract

MiR-205-5p promoted lung cancer cell proliferation and metastasis by negatively regulating the novel target TP53INP1, which further affected the expression of P21, RB1, and cyclin D1. Serum miR-205-5p is a novel and valuable biomarker for lung cancer diagnosis.